Revance Therapeutics Inc (RVNC)
3.075
0.00 (0.00%)
USD |
NASDAQ |
Dec 24, 12:14
Revance Therapeutics Free Cash Flow: -194.91M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Recursion Pharmaceuticals Inc | -335.64M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Ligand Pharmaceuticals Inc | 6.968M |
| MEI Pharma Inc | -43.43M |
| Cellectar Biosciences Inc | -46.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.09M |
| Cash from Investing (Quarterly) | 23.29M |
| Cash from Financing (Quarterly) | -6.087M |
| Free Cash Flow Per Share (Quarterly) | -0.3949 |
| Free Cash Flow to Equity (Quarterly) | -41.76M |
| Free Cash Flow to Firm (Quarterly) | -36.88M |
| Free Cash Flow Yield | -65.52% |